BlackRock Health Sciences Trust has seen some strong performance recently, yet still trades at a -7.8% discount to NAV, offering compelling value. BME removed its options-writing strategy, eliminating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results